Enabling access to new WHO essential medicines: The case for nicotine replacement therapies Journal Article


Authors: Kishore, S. P.; Bitton, A.; Cravioto, A.; Yach, D.
Article Title: Enabling access to new WHO essential medicines: The case for nicotine replacement therapies
Abstract: Nicotine replacement therapies (NRT) are powerful tools for the successful treatment of nicotine addiction and tobacco use. The medicines are clinically effective, supported by the Framework Convention on Tobacco Control, and are now World Health Organization-approved essential medicines. Enabling global access to NRT remains a challenge given ongoing confusion and misperceptions about their efficacy, cost-effectiveness, and availability with respect to other tobacco control and public health opportunities. In this commentary, we review existing evidence and guidelines to make the case for global access to NRT highlighting the smoker's right to access treatment to sensibly address nicotine addiction. © 2010 Kishore et al; licensee BioMed Central Ltd.
Keywords: note; smoking cessation; smoking; practice guideline; cost effectiveness analysis; drug cost; tobacco dependence; world health organization; nicotiana tabacum; patient counseling; drug industry; nicotine replacement therapy; nicotine gum
Journal Title: Globalization and Health
Volume: 6
ISSN: 1744-8603
Publisher: Biomed Central Ltd  
Date Published: 2010-11-19
Start Page: 22
Language: English
DOI: 10.1186/1744-8603-6-22
PROVIDER: scopus
PMCID: PMC2994846
PUBMED: 21092092
DOI/URL:
Notes: --- - "Export Date: 20 April 2011" - "Art. No.: 22" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sandeep   Kishore
    18 Kishore